Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL9 | O00512 | 1/20 | 0.50 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.40 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.40 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | MGLL | Q99685 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20436303 | 0.79 | MGLL (0.46) | BCL9CTNNB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL20458576 | 0.74 | KMT2A (0.43) | BCL9CTNNB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL7161403 | 0.69 | BCL9 (0.71) | BCL9CTNNB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL133257 | 0.69 | BCL9 (1.00) | BCL9CTNNB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL957930 | 0.69 | BCL9 (0.81) | BCL9CTNNB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL13701877 | 0.68 | BCL9 (0.69) | BCL9CTNNB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL26111924 | 0.68 | BCL9 (0.97) | BCL9CTNNB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL828974 | 0.67 | BCL9 (0.82) | BCL9CTNNB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL7357068 | 0.67 | PTPN7 (0.72) | BCL9CTNNB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL2294100 | 0.66 | BCL9 (0.76) | BCL9CTNNB1KMT2ASMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11327060-B2 | Method for analyzing enantiomer | AJINOMOTO CO., INC. (JP) | 2022-05-10 | — | — | US | disclosed |
| US-20180217113-A1 | METHOD FOR ANALYZING ENANTIOMER | AJINOMOTO CO., INC. (JP) | 2018-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11327060-B2 | Method for analyzing enantiomer | DCX, INF2, SRD5A2 | BCL9 2296/4885CTNNB1 329/4885KMT2A 1985/4885 |
| US-20180217113-A1 | METHOD FOR ANALYZING ENANTIOMER | DCX, INF2, SRD5A2 | BCL9 2296/4885CTNNB1 329/4885KMT2A 1985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.